secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zura Bio Ltd (ZURA)
CIK:        0001855644
Form:       8-K
Filed at:   2023-03-16T23:59:59+00:00
Accession:  0001104659-23-033380
Event type: m_and_a
Sentiment:  positive
Materiality: 0.90
Item codes: 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

JATT shareholders approve business combination with Zura Bio; closing expected March 20
--------------------------------------------------------------------------------

- Shareholders voted 4,903,764 for (99.9% of votes cast) vs 4,099 against to adopt the Business Combination Agreement.
- Closing expected on March 20, 2023; combined company to trade on Nasdaq as ZURA (shares) and ZURAW (warrants) starting March 21.
- Holders of 4,907,863 ordinary shares (95.5% of outstanding) were present or represented at the March 16 extraordinary general meeting.
- All other proposals – Charter amendments, director elections, equity plans – also approved by similar margins.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855644/000110465923033380/0001104659-23-033380-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855644/000110465923033380/tm239794d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-033380

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer